

At DK Pharmachem, our Quality Management System is built in full alignment with ICH guidelines and is 21 CFR compliant, ensuring that our operations consistently meet stringent international quality requirements. Within this system, we conduct in-house Analytical Method Validation (AMV) and Process Validation (PV), alongside comprehensive stability and hold-time studies for APIs and intermediates.
Our Quality Control laboratory is equipped with advanced technology, while our Quality Assurance experts oversee every process with accuracy and precision. By integrating these systems, we not only achieve compliance but also guarantee reliability, reproducibility, and trust for every partner we serve worldwide.

We meet the toughest global standards

We validate and confirm every process
Our team excels in implementing and maintaining rigorous QMS knowledge that
drive

21CFR Part 11 compliant

State-of-the-art QC Department with latest equipment’s like IR / GC / HPLC / UV and Karl Fischer

In-house Long term and Short term stability studies

Drug Master File supported by our Quality Control division

Manufacturing & Documentation of Intermediates as per GMP norms

Quality Compliance of APIs for IP, EP, BP, USP, JP and CP

Robust Regulatory and QA department ensures stringent quality control

APIs are manufactured as per ICH Q7A guidelines / GMP norms

ISO 9001-2008 certified

Written confi rmation certifi cates

WHO GMP certified

SME 1 and D & B rating as 4A2

Successfully Audited by top Multinationals

QA is well versed with documentation and compliances

In-house Analytical Method Validation for APIs & Intermediates
DK PharmaChem holds WHO Good Manufacturing Practice (WHO-GMP) certification, ISO 9001:2015 certification and European Union (EU) Written Confirmation certificates for API exports. Its Quality Management System is aligned with International Council for Harmonisation (ICH) guidelines, and APIs are manufactured under ICH Q7A GMP norms. Quality Control operations are compliant with 21 CFR Part 11.
DK PharmaChem lists accreditations or approvals associated with the European Directorate for the Quality of Medicines (EDQM) through its Certificates of Suitability (CEP), Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), Australia’s Therapeutic Goods Administration (TGA), the Ministry of Health (MOH), China’s National Medical Products Administration (NMPA) and Center for Drug Evaluation (CDE), South Korea’s Ministry of Food and Drug Safety (MFDS) and Italy’s Agenzia Italiana del Farmaco (AIFA). Approvals are product-specific, so buyers should confirm the status of each molecule.
DK PharmaChem’s APIs are quality compliant with the Indian Pharmacopoeia (IP), European Pharmacopoeia (EP), British Pharmacopoeia (BP), United States Pharmacopeia (USP), Japanese Pharmacopoeia (JP) and Chinese Pharmacopoeia (CP). Compliance is confirmed per product, so buyers should state the required monograph when requesting a quotation.
DK PharmaChem’s Quality Control laboratory is equipped with IR, GC, HPLC, UV and Karl Fischer instruments. The company conducts in-house Analytical Method Validation (AMV) and Process Validation (PV) for APIs and intermediates. It also runs long-term and short-term stability studies and hold-time studies. These capabilities support consistent, reproducible batches and the data packages buyers need for qualification.
Documentation depends on the product. DK PharmaChem’s Quality Control division supports Drug Master Files (DMF), and Certificates of Suitability (CEP) and Written Confirmation certificates are available for relevant products. Buyers can request specifications, certificates of analysis, validation summaries and stability data. Please share the product name and target market so the team can confirm which documents apply.